Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 195
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
BMC Cancer ; 23(1): 1164, 2023 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-38031020

RESUMO

BACKGROUND: Vaginal CO2 laser therapy is a new treatment option for genitourinary syndrome of menopause. Its potential is particularly interesting in breast cancer survivors, where existing treatment options often are insufficient as hormonal treatment is problematic in these women. The objective of this study is to investigate the effectiveness of vaginal laser treatment for alleviation of genitourinary syndrome of menopause in breast cancer survivors treated with adjuvant endocrine therapy. The secondary objective is to explore the importance of repeated vaginal laser treatment and the long-term effects in this patient population. METHODS: VagLaser consist of three sub-studies; a dose response study, a randomized, participant blinded, placebo-controlled study and a follow-up study. All studies include breast cancer survivors in adjuvant endocrine therapy, and are conducted at the Department of Obstetrics and Gynecology, Randers Regional Hospital, Denmark. The first participant was recruited on 16th of February 2023. Primary outcome is vaginal dryness. Secondary subjective outcomes are vaginal pain, itching, soreness, urinary symptoms and sexual function. Secondary objective outcomes are change in vaginal histology (punch biopsy), change in vaginal and urine microbiota, and change in vaginal pH. DISCUSSION: More randomized controlled trials, with longer follow-up to explore the optimal treatment regimen and the number of repeat vaginal laser treatments for alleviation the symptoms of genitourinary syndrome of menopause in breast cancer survivors treated with endocrine adjuvant therapy, are needed. This study will be the first to investigate change in vaginal and urine microbiota during vaginal laser therapy in breast cancer survivors. TRIAL REGISTRATION: ClinicalTrials.gov: NCT06007027 (registered 22 August, 2023). PROTOCOL VERSION: Version 1, Date 13.11.2023.


Assuntos
Neoplasias da Mama , Sobreviventes de Câncer , Doenças Urogenitais Femininas , Terapia a Laser , Neoplasias Urogenitais , Humanos , Feminino , Neoplasias da Mama/complicações , Dióxido de Carbono , Seguimentos , Terapia a Laser/efeitos adversos , Terapia a Laser/métodos , Doenças Urogenitais Femininas/terapia , Doenças Urogenitais Femininas/complicações , Menopausa , Vagina/cirurgia , Resultado do Tratamento , Ensaios Clínicos Controlados Aleatórios como Assunto
2.
Climacteric ; 24(2): 187-193, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33089713

RESUMO

PURPOSE: This study aimed to clarify the efficacy of intravaginal CO2-laser treatment in postmenopausal women with genitourinary syndrome of menopause (GSM). MATERIALS AND METHODS: This double-blind, randomized, sham-controlled trial included postmenopausal women diagnosed with GSM and bothersome dryness and dyspareunia. Treatment consisted of three sessions. Active CO2-laser treatments (active group) were compared to sham treatments (sham group) with the primary endpoints being changes in dryness and dyspareunia intensity, as assessed by the 10-cm visual analog scale. Secondary endpoints were as follows: changes in Female Sexual Function Index (FSFI; total score and all domains), itching, burning, dysuria, and Urogenital Distress Inventory (UDI-6); incidence of symptoms; and presence of adverse events. All outcomes were evaluated at baseline and 4 months post baseline. RESULTS: Fifty-eight women (28 in the active group and 30 in the sham group) were eligible for inclusion. In the active group, dryness, dyspareunia, FSFI (total score), itching, burning, dysuria, and UDI-6 were significantly improved (mean [standard deviation] -5.6 [2.8], -6 [2.6], 12.3 [8.9], -2.9 [2.8], -2.3 [2.8], -0.9 [2.1], and -8.0 [15.3], respectively). In the sham group, dryness, itching, and burning were significantly improved (-1.9 [2], -1.4 [1.9], and -1 [1.9], respectively). All changes were in favor of the active group. After completion of the protocol, the proportion of participants with dryness, dyspareunia, and sexual dysfunction was significantly lower in the active group compared to those in the sham group (all p < 0.005). CONCLUSIONS: CO2 laser could be proposed as an effective alternative treatment for the management of GSM as it is superior to sham treatments.


Assuntos
Doenças Urogenitais Femininas/cirurgia , Lasers de Gás/uso terapêutico , Pós-Menopausa , Vagina/cirurgia , Dióxido de Carbono , Método Duplo-Cego , Dispareunia/etiologia , Dispareunia/cirurgia , Feminino , Doenças Urogenitais Femininas/complicações , Humanos , Pessoa de Meia-Idade , Medição da Dor , Disfunções Sexuais Fisiológicas/etiologia , Disfunções Sexuais Fisiológicas/cirurgia , Síndrome , Resultado do Tratamento , Doenças Vaginais/etiologia , Doenças Vaginais/cirurgia
3.
Clin Genet ; 97(1): 179-197, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-30916780

RESUMO

This article provides an overview of the current knowledge on medical complications, health characteristics, and psychosocial issues in adults with achondroplasia. We have used a scoping review methodology particularly recommended for mapping and summarizing existing research evidence, and to identify knowledge gaps. The review process was conducted in accordance with the PRISMA-ScR guidelines (Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews). The selection of studies was based on criteria predefined in a review protocol. Twenty-nine publications were included; 2 reviews, and 27 primary studies. Key information such as reference details, study characteristics, topics of interest, main findings and the study author's conclusion are presented in text and tables. Over the past decades, there has only been a slight increase in publications on adults with achondroplasia. The reported morbidity rates and prevalence of medical complications are often based on a few studies where the methodology and representativeness can be questioned. Studies on sleep-related disorders and pregnancy-related complications were lacking. Multicenter natural history studies have recently been initiated. Future studies should report in accordance to methodological reference standards, to strengthen the reliability and generalizability of the findings, and to increase the relevance for implementing in clinical practice.


Assuntos
Acondroplasia/complicações , Acondroplasia/mortalidade , Acondroplasia/fisiopatologia , Acondroplasia/psicologia , Adulto , Doenças Ósseas/complicações , Feminino , Doenças Urogenitais Femininas/complicações , Humanos , Obesidade/complicações , Otorrinolaringopatias/complicações , Dor/complicações , Gravidez , Qualidade de Vida , Reprodutibilidade dos Testes , Transtornos Respiratórios/complicações , Transtornos do Sono-Vigília , Estenose Espinal/complicações
4.
Medicina (Kaunas) ; 56(1)2020 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-31952297

RESUMO

Introduction: Extended pelvic resection might be the option of choice in patients presenting locally advanced cervical cancer. However, the possibility of a co-existence of an ectopic, pelvic kidney that is invaded by such a tumor is extremely rare. Case Presentation: A 54-year-old female patient, diagnosed with locally advanced cervical cancer in the presence of a pelvic kidney, was submitted to surgery with curative intent. A large, abscessed cervical tumor invading the urinary bladder and the rectum was found, so a total exenteration was planned. Intraoperatively, tumor invasion of the left kidney, which was found in an ectopic, pelvic position was also encountered; therefore, total pelvic exenteration in association with a left nephrectomy was successfully performed. Conclusions: The presence of an ectopic, pelvic disposition of the kidney makes it susceptible to be invaded by locally advanced pelvic tumors; in such cases, a nephrectomy might also be needed.


Assuntos
Coristoma/cirurgia , Doenças Urogenitais Femininas/cirurgia , Rim , Nefrectomia/métodos , Exenteração Pélvica/métodos , Neoplasias do Colo do Útero/cirurgia , Coristoma/complicações , Coristoma/patologia , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/patologia , Humanos , Pessoa de Meia-Idade , Invasividade Neoplásica , Pelve/patologia , Pelve/cirurgia , Neoplasias do Colo do Útero/complicações , Neoplasias do Colo do Útero/patologia
5.
Pain Med ; 20(7): 1321-1329, 2019 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-30252113

RESUMO

OBJECTIVE: Women with chronic urogenital pain (CUP) conditions have elevated rates of lifetime trauma, relational stress, and emotional conflicts, but directly assessing and treating psychological stress is rarely done in women's health care settings. We developed and tested the effects on patients' somatic and psychological symptoms of a life stress interview that encourages disclosure about stressors and uses experiential techniques to increase awareness of links between stress, emotions, and symptoms. METHODS: In this randomized trial, women with CUP recruited at a multidisciplinary women's urology center received either a single 90-minute life stress interview (N = 37) or no interview (treatment-as-usual control; N = 25). Self-report measures of pain severity (primary outcome), pain interference, pelvic floor symptoms, and psychological symptoms (anxiety and depression) were completed at baseline and six-week follow-up. RESULTS: Differences between the life stress interview and control conditions at follow-up were tested with analyses of covariance, controlling for baseline level of the outcome and baseline depression. Compared with the control condition, the interview resulted in significantly lower pain severity and pelvic floor symptoms, but the interview had no effect on pain interference or psychological symptoms. CONCLUSIONS: An intensive life stress emotional awareness expression interview improved physical but not psychological symptoms among women with CUP seen in a tertiary care clinic. This study suggests that targeting stress and avoided emotions and linking them to symptoms may be beneficial for this complex group of patients.


Assuntos
Dor Crônica/psicologia , Dor Crônica/terapia , Doenças Urogenitais Femininas/psicologia , Angústia Psicológica , Psicoterapia/métodos , Adulto , Depressão/psicologia , Feminino , Doenças Urogenitais Femininas/complicações , Humanos , Entrevistas como Assunto , Pessoa de Meia-Idade , Manejo da Dor/métodos
6.
Lasers Surg Med ; 49(2): 160-168, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27546524

RESUMO

OBJECTIVES: The objective of this prospective comparative cohort study was to establish the effectiveness and safety of Erbium:YAG (Er:YAG) laser treatment for genitourinary syndrome of menopause and to compare it with an established topical estriol treatment. METHODS: Fifty patients with genitourinary syndrome of menopause were divided into two groups. The estriol group received a treatment of 0.5 mg estriol ovules for 8 weeks and the laser group was first treated for 2 weeks with 0.5 mg estriol ovules 3 times per week to hydrate the mucosa and then received three sessions with 2,940 nm Er:YAG laser in non-ablative mode. Biopsies were taken before and at 1, 3, 6, and 12 months post-treatment. Maturation index, maturation value and pH where recorded up to 12-months post-treatment, while the VAS analysis of symptoms was recorded up to 18 months post-treatment. RESULTS: Statistically significant (P < 0.05), reduction of all assessed symptoms was observed in the laser group at all follow-ups up to 18 months post-treatment. Significant improvement in maturation value and a decrease of pH in the laser group was detected up to 12 months after treatment. The improvement in all endpoints was more pronounced and longer lasting in the laser group. Histological examination showed changes in the tropism of the vaginal mucosa and also angiogenesis, congestion, and restructuring of the lamina propria in the laser group. Side effects were minimal and of transient nature in both groups, affecting 4% of patients in the laser group and 12% of patients in the estriol group. CONCLUSIONS: Our results show that Er:YAG laser treatment successfully relieves symptoms of genitourinary syndrome of menopause and that the results are more pronounced and longer lasting compared to topical estriol treatment. Lasers Surg. Med. 49:160-168, 2017. © 2016 The Authors. Lasers in Surgery and Medicine Published by Wiley Periodicals, Inc.


Assuntos
Doenças Urogenitais Femininas/terapia , Terapia a Laser , Lasers de Estado Sólido/uso terapêutico , Menopausa , Administração Tópica , Estriol , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/patologia , Humanos , Pessoa de Meia-Idade , Projetos Piloto , Estudos Prospectivos , Síndrome , Resultado do Tratamento
7.
Nurs Outlook ; 65(5S): S17-S25, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28800835

RESUMO

BACKGROUND: The recent removal of United States military combat exclusion rules resulted in more women serving in forward deployed austere conditions. In the deployed setting, women were diagnosed with genitourinary (GU) conditions five times greater than men. PURPOSE: Describe deployed military women's GU illness behaviors. METHOD: Two qualitative descriptive studies interviewing military women and enlisted medics were synthesized using the Illness Behavior Model. DISCUSSION: Similar and divergent views on the impact of the military culture of the illness behaviors were described by women and medics. Both agreed appropriate attention on managing GU symptoms must continue; however differing strategies were appraised. One agreed option was to offer a health care mentor. CONCLUSION: The Illness Behavior Model provided an excellent framework for evaluation of military women's illness behaviors exposing areas for comparing and contrasting the perspectives provided. While significant changes have been made, additional strategies will continue to improve the women's deployed health care quality.


Assuntos
Doenças Urogenitais Femininas/psicologia , Comportamento de Doença , Militares , Adaptação Psicológica , Adulto , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/terapia , Humanos , Modelos Teóricos , Aceitação pelo Paciente de Cuidados de Saúde , Pesquisa Qualitativa , Autocuidado , Estados Unidos , Exposição à Guerra , Adulto Jovem
8.
Georgian Med News ; (268-269): 80-885, 2017.
Artigo em Russo | MEDLINE | ID: mdl-28820419

RESUMO

The aim of this work was to assess the state of the fallopian tubes in women with urogenital chlamydia (UC) and infertility. 344 women 18-49 y.o with infertility have been investigated. UC was detected in 133 of them -38.7%, (main group), UC was absent in 211 (61.3%) patients (comparision group). In the main group prevailed the tubal or tubal peritoneal factor of infertility (51.9% versus 19.4% in the comparison group, p<0.001). UC in women in the main (62.4%) was in the form of mixed infection. Obstruction of the fallopian tubes and adhesions in the pelvic region were more often detected in patients of the main group (p<0.05). The most pronounced lesions of the fallopian tubes were observed in women with chlamydial mixed infection. Adhesive process in the small pelvis was established by laparascopy in 72.2% of women in the main group and in 27.8% in the comparison group (p<0.001). There was a correlation between the extent of the adhesion process in the small pelvis and the presence of chlamydial mixed infection. A histological study was carried out of the tissues of the fallopian tubes in 12 women diagnosed with an ectopic pregnancy, 5 of whom had UC. Women with UC have alternating areas with signs of acute inflammation and various stages of the reparative processand in 4 women with UC the above mentioned signs and sclerosis were detected also in the the submucosa, which can cause destruction of the functional activities of the fallopian tubes and obstruction as well. All this causes a violation of the transport of spermatozoa, the embryo and leads to a ectopic pregnancy and infertility. Obtained results explain the inefficiency of restoring reproductive function in women after elimination of UC with preserved patency of the fallopian tubes.


Assuntos
Infecções por Chlamydia/patologia , Tubas Uterinas/patologia , Doenças Urogenitais Femininas/patologia , Infertilidade Feminina/patologia , Adolescente , Adulto , Infecções por Chlamydia/complicações , Infecções por Chlamydia/microbiologia , Chlamydia trachomatis/isolamento & purificação , Coinfecção , Tubas Uterinas/microbiologia , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/microbiologia , Humanos , Infertilidade Feminina/complicações , Infertilidade Feminina/microbiologia , Pessoa de Meia-Idade , Adulto Jovem
9.
Br J Surg ; 103(10): 1343-9, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27465409

RESUMO

BACKGROUND: Diagnostic accuracy in the assessment of patients with acute abdominal pain in the emergency ward is not adequate. It has been argued that this is because the investigations are carried out predominantly by a trainee. Resource utilization could be lowered if surgeons had a higher initial diagnostic accuracy. METHODS: Patients with acute abdominal pain were included in a prospective cohort study. A surgical trainee and a surgeon made independent assessments in the emergency department, recording the clinical diagnosis and proposed diagnostic investigations. A reference standard diagnosis was established by an expert panel, and the proportion of correct diagnoses was calculated. Diagnostic accuracy was expressed in terms of sensitivity, specificity, positive predictive value and negative predictive value. Interobserver agreement for the diagnosis and elements of history-taking and physical examination were expressed by means of Cohen's κ. Certainty of diagnosis was recorded using a visual analogue scale. RESULTS: A trainee and a surgeon independently assessed 126 patients. Trainees made a correct diagnosis in 44·4 per cent of patients and surgeons in 42·9 per cent (P = 0·839). Surgeons, however, recorded a higher level of diagnostic certainty. Diagnostic accuracy was comparable in distinguishing urgent from non-urgent diagnoses, and for the most common diseases. Interobserver agreement for the clinical diagnosis varied from fair to moderate (κ = 0·28-0·57). CONCLUSION: The diagnostic accuracy of the initial clinical assessment is not improved when a surgeon rather than a surgical trainee assesses a patient with abdominal pain in the emergency department.


Assuntos
Abdome Agudo/etiologia , Competência Clínica/estatística & dados numéricos , Doenças do Sistema Digestório/diagnóstico , Doenças Urogenitais Femininas/diagnóstico , Internato e Residência , Doenças Urogenitais Masculinas/diagnóstico , Cirurgiões/normas , Adulto , Doenças do Sistema Digestório/complicações , Serviço Hospitalar de Emergência , Feminino , Doenças Urogenitais Femininas/complicações , Humanos , Masculino , Doenças Urogenitais Masculinas/complicações , Pessoa de Meia-Idade , Países Baixos , Variações Dependentes do Observador , Valor Preditivo dos Testes , Estudos Prospectivos , Padrões de Referência , Sensibilidade e Especificidade , Cirurgiões/educação , Cirurgiões/estatística & dados numéricos
10.
Sex Transm Dis ; 43(9): 584-6, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27513386

RESUMO

We report the first case of reactive arthritis associated with lymphogranuloma venereum (LGV) in an Italian human immunodeficiency virus-negative woman with urogenital and rectal Chlamydia trachomatis L2 serovar infection. The LGV-associated arthritis has to be considered even when classic symptoms of arthritis are missing and in case of asymptomatic or cryptic LGV localizations.


Assuntos
Artrite Reativa/microbiologia , Chlamydia trachomatis , Doenças Urogenitais Femininas/complicações , Linfogranuloma Venéreo/complicações , Doenças Retais/complicações , Feminino , Doenças Urogenitais Femininas/microbiologia , Humanos , Pessoa de Meia-Idade , Doenças Retais/microbiologia
11.
Ultrasound Obstet Gynecol ; 47(3): 363-8, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25854801

RESUMO

OBJECTIVES: Female pelvic organ prolapse is quantified on clinical examination using the pelvic organ prolapse quantification system of the International Continence Society (ICS POP-Q). Pelvic organ descent on ultrasound is strongly associated with symptoms of prolapse, but associations between clinical and ultrasound findings remain unclear. This study was designed to compare clinical examination and imaging findings, especially regarding cut-offs for the distinction between normal pelvic organ support and prolapse. METHODS: This was a retrospective study using 839 archived datasets of women referred to a tertiary urogynecological center for symptoms of lower urinary tract and pelvic floor dysfunction between June 2011 and May 2013. The main outcome measures were the maximum downward displacement of the anterior vaginal wall (point Ba), the cervix (point C) and the posterior vaginal wall (point Bp), the length of the genital hiatus (Gh) and the length of the perineal body (Pb), as defined by the ICS POP-Q; explanatory parameters were measures of pelvic organ descent on translabial ultrasound, ascertained by offline volume data analysis at a later date, by an operator blinded to all other data. RESULTS: Full datasets were available for 825 women. On clinical examination, 646 (78.3%) were found to have prolapse of at least POP-Q Stage 2. All coordinates on clinical examination were strongly associated with the ultrasound measurements of pelvic organ descent (P < 0.001). These relationships were almost linear, especially for the anterior compartment. CONCLUSIONS: There is a near linear relationship between sonographic and clinical measures of prolapse. Previously proposed cut-offs to define 'significant prolapse' on ultrasound and POP-Q (Ba ≥ -0.5 and cystocele ≥ 10 mm below the symphysis pubis, C ≥ -5 and uterine position of 15 mm above the symphysis pubis, Bp ≥ -0.5 and rectocele ≥ 15 mm below the symphysis pubis) are plausible and mutually consistent. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.


Assuntos
Doenças Urogenitais Femininas/complicações , Prolapso de Órgão Pélvico/diagnóstico por imagem , Prolapso de Órgão Pélvico/patologia , Ultrassonografia/métodos , Adulto , Idoso , Cistocele/diagnóstico por imagem , Feminino , Doenças Urogenitais Femininas/diagnóstico por imagem , Humanos , Pessoa de Meia-Idade , Diafragma da Pelve/patologia , Retocele/diagnóstico por imagem , Estudos Retrospectivos , Bexiga Urinária/diagnóstico por imagem , Útero/diagnóstico por imagem
12.
Int Urogynecol J ; 27(1): 147-50, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25910611

RESUMO

INTRODUCTION AND HYPOTHESIS: Endometriosis involving the sacral plexus is still poorly understood or neglected by many surgeons. Looking at that scenario, we have designed this educational video to explain and describe the symptoms suggestive of endometriotic involvement of the sacral plexus in addition to the technique for the laparoscopic treatment of this condition. METHODS: Retrospective analysis of 13 consecutive cases of endometriotic entrapment of nerves of the lumbosacral plexus. RESULTS: Paired t test revealed a statistically significant (p < 0.0000001) reduction in pain VAS score, from preoperative average 9.1 (±1.98) to postoperative 1.46 (±1.66). Twelve out of 13 patients (92.3%) experienced a reduction of 50% or more in VAS score and 6 (46.15%) became completely pain-free. CONCLUSION: The signs suggestive of intrapelvic nerve involvement include perineal pain or pain irradiating to the lower limbs, lower urinary tract symptoms, tenesmus or dyschezia associated with gluteal pain. Whenever deeply infiltrating lesions are present, the patient must be asked about those symptoms and specific MRI sequences for the sacral plexus must be taken, so that the equipment and team can be arranged and proper treatment performed.


Assuntos
Endometriose/complicações , Doenças Urogenitais Femininas/complicações , Plexo Lombossacral , Síndromes de Compressão Nervosa/etiologia , Raízes Nervosas Espinhais , Adulto , Endometriose/diagnóstico , Endometriose/terapia , Feminino , Humanos , Laparoscopia , Síndromes de Compressão Nervosa/diagnóstico , Síndromes de Compressão Nervosa/cirurgia , Dor Pélvica , Estudos Retrospectivos
13.
J Adv Nurs ; 71(2): 391-403, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25134858

RESUMO

AIMS: To identify predictive factors associated with the development of pressure ulcers in patients at risk who receive standardized preventive care. BACKGROUND: Numerous studies have examined factors that predict risk for pressure ulcer development. Only a few studies identified risk factors associated with pressure ulcer development in hospitalized patients receiving standardized preventive care. DESIGN: Secondary analyses of data collected in a multicentre randomized controlled trial. METHODS: The sample consisted of 610 consecutive patients at risk for pressure ulcer development (Braden Score <17) receiving standardized preventive care measures. Patient demographic information, data on skin and risk assessment, medical history and diagnosis were collected during 26 months (December 2007-January 2010). Predictive factors were identified using multivariate statistics. RESULTS: Pressure ulcers in category II-IV were significantly associated with non-blanchable erythema, urogenital disorders and higher body temperature. Predictive factors significantly associated with superficial pressure ulcers were admission to an internal medicine ward, incontinence-associated dermatitis, non-blanchable erythema and a lower Braden score. Superficial sacral pressure ulcers were significantly associated with incontinence-associated dermatitis. CONCLUSIONS: Despite the standardized preventive measures they received, hospitalized patients with non-blanchable erythema, urogenital disorders and a higher body temperature were at increased risk for developing pressure ulcers. RELEVANCE TO CLINICAL PRACTICE: Improved identification of at-risk patients can be achieved by taking into account specific predictive factors. Even if preventive measures are in place, continuous assessment and tailoring of interventions is necessary in all patients at risk. Daily skin observation can be used to continuously monitor the effectiveness of the intervention.


Assuntos
Úlcera por Pressão/etiologia , Idoso , Idoso de 80 Anos ou mais , Eritema/complicações , Feminino , Doenças Urogenitais Femininas/complicações , Febre/complicações , Humanos , Masculino , Doenças Urogenitais Masculinas/complicações , Úlcera por Pressão/prevenção & controle , Medição de Risco
14.
Lik Sprava ; (7-8): 112-7, 2015.
Artigo em Ucraniano | MEDLINE | ID: mdl-27491162

RESUMO

The results of a survey of 248 patients (mean age--26.0 years +/- 7.4 years), from which 222 patients (mean age--26.3 years +/- 8.0 years) with diseases of temporomandibular joint. Identified and visceral connection between the local changes in the iris, the state of the body's connective tissue, the presence of visceral disease (cardiovascular, respiratory, digestive, urinary system), diseases of the temporomandibular joints. Key words: temporomandibular joint, connective tissue, iris, iridodiagnostic, internal organs, concomitant diseases, topical. diagnostics.


Assuntos
Doenças Cardiovasculares/diagnóstico , Doenças do Sistema Digestório/diagnóstico , Doenças Urogenitais Femininas/diagnóstico , Doenças Urogenitais Masculinas/diagnóstico , Transtornos Respiratórios/diagnóstico , Transtornos da Articulação Temporomandibular/diagnóstico , Articulação Temporomandibular/patologia , Adolescente , Adulto , Doenças Cardiovasculares/complicações , Doenças Cardiovasculares/patologia , Tecido Conjuntivo/patologia , Doenças do Sistema Digestório/complicações , Doenças do Sistema Digestório/patologia , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/patologia , Humanos , Iris/patologia , Masculino , Doenças Urogenitais Masculinas/complicações , Doenças Urogenitais Masculinas/patologia , Transtornos Respiratórios/complicações , Transtornos Respiratórios/patologia , Avaliação de Sintomas , Transtornos da Articulação Temporomandibular/complicações , Transtornos da Articulação Temporomandibular/patologia
15.
Mikrobiol Z ; 77(6): 39-46, 2015.
Artigo em Ucraniano | MEDLINE | ID: mdl-26829838

RESUMO

The own observations results of urogenital, gastrointestinal and nasopharyngeal infectious factors that cause the development of reactive arthritis (PeA) are being presented. The greatest contribution to the development of this disease make Chlamidia trachomatis (36%), Streptococcus haemolyticus (pyogenes) (19%) and hepatitis viruses B and C (10%). As a result of the research a number of kinetic parameters of arginase and NO-synthase reactions in peripheral blood lymphocytes of patients with reactive arthritis was identified. The authentic increase of arginase activity in 3.3 times and eNO-synthase activity decrease by 1,9 times in peripheral blood lymphocytes of patients with PeA, compared to practically healthy donors were determined. Increased activity of arginase and iNO-synthase of lymphocytes indicates changes in immune cells functional activity, which may be due to impaired metabolic and regulatory processes in these cells caused by a bacterial or viral infection.


Assuntos
Arginase/metabolismo , Artrite Reativa/microbiologia , Artrite Reativa/virologia , Leucócitos Mononucleares/microbiologia , Leucócitos Mononucleares/virologia , Óxido Nítrico Sintase Tipo III/metabolismo , Óxido Nítrico/metabolismo , Adulto , Artrite Reativa/complicações , Artrite Reativa/imunologia , Infecções Bacterianas/complicações , Infecções Bacterianas/imunologia , Infecções Bacterianas/microbiologia , Estudos de Casos e Controles , Chlamydia trachomatis/classificação , Chlamydia trachomatis/isolamento & purificação , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/imunologia , Doenças Urogenitais Femininas/microbiologia , Doenças Urogenitais Femininas/virologia , Gastroenteropatias/complicações , Gastroenteropatias/imunologia , Gastroenteropatias/microbiologia , Gastroenteropatias/virologia , Hepacivirus/classificação , Hepacivirus/isolamento & purificação , Hepatite/complicações , Hepatite/imunologia , Hepatite/virologia , Vírus da Hepatite B/classificação , Vírus da Hepatite B/isolamento & purificação , Humanos , Leucócitos Mononucleares/imunologia , Masculino , Doenças Urogenitais Masculinas/complicações , Doenças Urogenitais Masculinas/imunologia , Doenças Urogenitais Masculinas/microbiologia , Doenças Urogenitais Masculinas/virologia , Doenças Nasofaríngeas/complicações , Doenças Nasofaríngeas/imunologia , Doenças Nasofaríngeas/microbiologia , Doenças Nasofaríngeas/virologia , Cultura Primária de Células , Streptococcus pyogenes/classificação , Streptococcus pyogenes/isolamento & purificação
16.
J Obstet Gynaecol Res ; 40(4): 1132-6, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24612049

RESUMO

Malignant degeneration of endometriosis in the inguinal region is rare, and has only been reported in six cases in the literature, none of which was detected during pregnancy. We present the first case of endometriosis-associated adenocarcinoma in the inguinal region in a 34-year-old woman who was 35 weeks' pregnant. The tumor rapidly grew in the last 2 months of pregnancy as a left inguinal painful mass. Histologically, the tumor consisted of a moderate-to-poorly differentiated ovarian-type endometrioid adenocarcinoma arisen in endometriosis foci of both typical and atypical type. Elective labor induction was performed at 35 weeks of gestation and subsequently the patient underwent a conservative surgical treatment followed by chemotherapy. This case raises issues on the management of such an unusual tumor both during and outside pregnancy.


Assuntos
Neoplasias Abdominais/diagnóstico , Carcinoma Endometrioide/diagnóstico , Endometriose/diagnóstico , Doenças Urogenitais Femininas/diagnóstico , Canal Inguinal , Complicações Neoplásicas na Gravidez/diagnóstico , Complicações na Gravidez/diagnóstico , Neoplasias Abdominais/complicações , Neoplasias Abdominais/tratamento farmacológico , Neoplasias Abdominais/cirurgia , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carboplatina/administração & dosagem , Carboplatina/uso terapêutico , Carcinoma Endometrioide/complicações , Carcinoma Endometrioide/tratamento farmacológico , Carcinoma Endometrioide/cirurgia , Quimioterapia Adjuvante , Endometriose/complicações , Endometriose/fisiopatologia , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/fisiopatologia , Humanos , Trabalho de Parto Induzido , Paclitaxel/administração & dosagem , Paclitaxel/uso terapêutico , Dor Pélvica/etiologia , Gravidez , Complicações na Gravidez/fisiopatologia , Complicações Neoplásicas na Gravidez/fisiopatologia , Terceiro Trimestre da Gravidez , Nascimento Prematuro , Diagnóstico Pré-Natal , Resultado do Tratamento
17.
Klin Med (Mosk) ; 92(5): 63-6, 2014.
Artigo em Russo | MEDLINE | ID: mdl-25782310

RESUMO

Statistical data on osteo-muscular morbidity in Kazakhstan are presented. Their comparative analysis revealed a 5% rise in general morbidity and a 1% rise in the frequency of urogenic Chlamydial infection. The frequency of inflammatory joint diseases including urogenic reactive arthritis among the patients of a military hospital amounted to 51%.


Assuntos
Artrite Reativa , Infecções por Chlamydia , Doenças Urogenitais Femininas , Doenças Urogenitais Masculinas , Adulto , Artrite Reativa/epidemiologia , Artrite Reativa/etiologia , Infecções por Chlamydia/complicações , Infecções por Chlamydia/epidemiologia , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/epidemiologia , Humanos , Cazaquistão/epidemiologia , Masculino , Doenças Urogenitais Masculinas/complicações , Doenças Urogenitais Masculinas/epidemiologia
18.
Lik Sprava ; (7-8): 73-5, 2014.
Artigo em Ucraniano | MEDLINE | ID: mdl-26118087

RESUMO

The article presents analysis of ultrasound examination of 45 reproductive age women with pulmonary tuberculosis and diseases of genitalia, among them high portion of genital tuberculosis. It is shown high diagnostic value of sonography and dopplerometry in early determination of reproductive function disorders in women with tuberculosis.


Assuntos
Doenças Urogenitais Femininas/diagnóstico , Complicações Infecciosas na Gravidez/diagnóstico , Reprodução , Tuberculose Pulmonar/complicações , Feminino , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/diagnóstico por imagem , Doenças Urogenitais Femininas/microbiologia , Humanos , Gravidez , Complicações Infecciosas na Gravidez/diagnóstico por imagem , Complicações Infecciosas na Gravidez/microbiologia , Tuberculose Pulmonar/diagnóstico por imagem , Tuberculose Pulmonar/microbiologia , Ultrassonografia
19.
Arch Esp Urol ; 77(4): 385-390, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38840281

RESUMO

BACKGROUND: Urinary incontinence is common in patients with genitourinary syndrome of menopause (GSM). A retrospective cohort study was conducted to analyse the clinical efficacy of carbon dioxide laser combined with pelvic floor functional exercise for GSM with urinary incontinence, aiming to provide evidence for its clinical treatment. METHODS: Patients diagnosed with GSM and urinary incontinence and admitted to our hospital from January 2021 to December 2022 were included and allocated to a control group (pelvic floor function exercise) and combined group (carbon dioxide laser combined with pelvic floor function exercise). Confounding factors among the groups were balanced by the propensity score matching method. The clinical efficacy, GSM scale scores, urinary indicators, urinary incontinence quality of life scale (I-QOL) scores and the degree of urinary incontinence of the groups were compared. RESULTS: A total of 192 patients were included in this study, and 36 cases were included in each group after the propensity scores were matched. No statistical difference in baseline data was found between the groups (p > 0.05). The combined group had higher total effective rate and I-QOL scores but lower GSM symptom scale scores than the control group. Urination during daytime and nighttime was less frequent in the combined group than in the control group, which showed a lower degree of urinary incontinence (p < 0.05). CONCLUSIONS: Combining carbon dioxide laser treatment with pelvic floor exercises is potentially effective for patients with GSM and urinary incontinence. This combined approach not only alleviated GSM and urinary incontinence symptoms but also reduced the severity of urinary incontinence, promoted bladder function recovery and enhanced overall quality of life.


Assuntos
Terapia por Exercício , Lasers de Gás , Diafragma da Pelve , Incontinência Urinária , Humanos , Feminino , Incontinência Urinária/etiologia , Incontinência Urinária/terapia , Estudos Retrospectivos , Pessoa de Meia-Idade , Terapia por Exercício/métodos , Lasers de Gás/uso terapêutico , Síndrome , Menopausa , Terapia Combinada , Doenças Urogenitais Femininas/complicações , Resultado do Tratamento , Estudos de Coortes
20.
Investig Clin Urol ; 65(3): 230-239, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38714513

RESUMO

PURPOSE: Pudendal neuropathy is an uncommon condition that exhibits several symptoms depending on the site of nerve entrapment. This study aims to evaluate the efficacy of pudendal nerve neurolysis (PNN) in improving lower urinary tract symptoms, anal and/or urinary incontinence, and sexual dysfunctions. MATERIALS AND METHODS: A systematic literature search was performed on 20 May 2023 using Scopus, PubMed, and Embase. Only English and adult papers were included. Meeting abstracts and preclinical studies were excluded. RESULTS: Twenty-one papers were accepted, revealing significant findings in the field. The study identified four primary sites of pudendal nerve entrapment (PNE), with the most prevalent location likely being at the level of the Alcock canal. Voiding symptoms are commonly exhibited in patients with PNE. PNN improved both urgency and voiding symptoms, and urinary and anal incontinence but is less effective in cases of long-standing entrapment. Regarding sexual function, the recovery of the somatic afferent pathway results in an improvement in erectile function early after neurolysis. Complete relief of persistent genital arousal disorder occurs in women, although bilateral PNN is necessary to achieve the efficacy. PNN is associated with low-grade complications. CONCLUSIONS: PNN emerges as a viable option for addressing urinary symptoms, fecal incontinence, erectile dysfunction, and female sexual arousal in patients suffering from PNE with minimal postoperative morbidity.


Assuntos
Nervo Pudendo , Neuralgia do Pudendo , Humanos , Neuralgia do Pudendo/complicações , Incontinência Fecal/etiologia , Incontinência Fecal/terapia , Resultado do Tratamento , Disfunções Sexuais Fisiológicas/etiologia , Bloqueio Nervoso/métodos , Doenças Urogenitais Masculinas , Doenças Urogenitais Femininas/complicações , Doenças Urogenitais Femininas/cirurgia , Incontinência Urinária/etiologia , Incontinência Urinária/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA